ReviewAmerican journal of clinical dermatology2020

Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?

Patrick Schummer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.